J FrontierJ Frontier Co.,Ltd.2934東証グロース情報・通信業FY ending May 2026, consolidated, J-GAAP
About 70% of J Frontier's sales come from Healthcare sales business, with Medical care sales business and Healthcare marketing business making up much of the rest.
Out of every ¥100 of sales, about ¥8 is left as operating profit.
Revenue changed +19.5% from the prior year, operating profit +294.3%.
Revenue +19.5% · profit +294.3%, calculated from disclosed figures.
Operating leverage: 15.08× (profit growth ÷ revenue growth)
FY ending May 2020 → FY ending May 2021
FY ending May 2020 → FY ending May 2021
For every ¥100 J Frontier sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書－第13期(令和2年6月1日－令和3年5月31日)
Extracted from XBRL: 41 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.